Mortezaei A, Taghlabi K, Al-Saidi N, Amasa S, Whitehead R, Hoang A
Neuroradiology. 2025; .
PMID: 40088307
DOI: 10.1007/s00234-025-03584-3.
Giurazza F, Lucatelli P, Corvino F, Argiro R, Roccatagliata P, Ierardi A
Diagnostics (Basel). 2025; 14(24.
PMID: 39767205
PMC: 11675833.
DOI: 10.3390/diagnostics14242844.
Etzel P, Drescher R, Burckenmeyer F, Freesmeyer M, Werner A
Biomedicines. 2024; 12(8).
PMID: 39200258
PMC: 11352075.
DOI: 10.3390/biomedicines12081794.
Gurajala R, Partovi S, DiFilippo F, Li X, Coppa C, Shah S
J Gastrointest Oncol. 2024; 15(1):356-367.
PMID: 38482235
PMC: 10932664.
DOI: 10.21037/jgo-23-890.
Mourad S, De la Garza-Ramos C, Toskich B
Cancers (Basel). 2024; 16(3).
PMID: 38339418
PMC: 10854641.
DOI: 10.3390/cancers16030669.
Analysis of the metastatic mechanism and progress in the treatment of breast cancer liver metastasis: a narrative review.
Liu G, Yang F, Gao L, Chen C, Wei J, Zheng Y
Transl Cancer Res. 2023; 12(6):1635-1646.
PMID: 37434684
PMC: 10331708.
DOI: 10.21037/tcr-22-2463.
Interventional radiological therapies in colorectal hepatic metastases.
Vulasala S, Sutphin P, Kethu S, Onteddu N, Kalva S
Front Oncol. 2023; 13:963966.
PMID: 37324012
PMC: 10266282.
DOI: 10.3389/fonc.2023.963966.
Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends.
Posa A, Contegiacomo A, Ponziani F, Punzi E, Mazza G, Scrofani A
Int J Mol Sci. 2023; 24(8).
PMID: 37108507
PMC: 10138371.
DOI: 10.3390/ijms24087344.
Post-embolization Syndrome Following Yttrium-90 Radiation Segmentectomy.
Vanani N, Janardan A, Asmi N, Jha P
Cureus. 2023; 15(3):e35947.
PMID: 37038587
PMC: 10082639.
DOI: 10.7759/cureus.35947.
Complications Related to Transarterial Treatment of Hepatocellular Carcinoma: A Comprehensive Review.
Lee H, Hyun D
Korean J Radiol. 2023; 24(3):204-223.
PMID: 36788765
PMC: 9971838.
DOI: 10.3348/kjr.2022.0395.
Intrahepatic flow diversion prior to segmental Yttrium-90 radioembolization for challenging tumor vasculature.
Young L, Kolber M, King M, Ranade M, Bishay V, Patel R
J Interv Med. 2022; 5(2):79-83.
PMID: 35936664
PMC: 9349007.
DOI: 10.1016/j.jimed.2022.02.001.
Intraarterial Therapies for the Management of Hepatocellular Carcinoma.
Garg T, Shrigiriwar A, Habibollahi P, Cristescu M, Liddell R, Chapiro J
Cancers (Basel). 2022; 14(14).
PMID: 35884412
PMC: 9322128.
DOI: 10.3390/cancers14143351.
The Role of Catheter-Directed CT-Angiography in Radioembolisation.
Zhuang K, Tong A, Ng D, Tay K
Cardiovasc Intervent Radiol. 2022; 45(11):1651-1658.
PMID: 35595985
DOI: 10.1007/s00270-022-03157-4.
Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma.
Vardar B, Meram E, Karaoglu K, Liang M, Yu M, Laeseke P
Cureus. 2022; 14(4):e23783.
PMID: 35518553
PMC: 9063732.
DOI: 10.7759/cureus.23783.
Tumour-to-normal tissue (T/N) dosimetry ratios role in assessment of Y selective internal radiation therapy (SIRT).
Knesaurek K, Bello Martinez R, Ghesani M
Br J Radiol. 2021; 95(1129):20210294.
PMID: 34762514
PMC: 8722260.
DOI: 10.1259/bjr.20210294.
Metastatic disease to the liver: Locoregional therapy strategies and outcomes.
Zane K, Cloyd J, Mumtaz K, Wadhwa V, Makary M
World J Clin Oncol. 2021; 12(9):725-745.
PMID: 34631439
PMC: 8479345.
DOI: 10.5306/wjco.v12.i9.725.
Biliary-Caval Fistula following Y90 Radioembolization.
Hall A, White S, Rilling W
Semin Intervent Radiol. 2021; 38(4):488-491.
PMID: 34629719
PMC: 8497092.
DOI: 10.1055/s-0041-1735605.
Recognizing and Managing Adverse Events in Y-90 Radioembolization.
Laidlaw G, Johnson G
Semin Intervent Radiol. 2021; 38(4):453-459.
PMID: 34629713
PMC: 8497076.
DOI: 10.1055/s-0041-1735617.
Radiation Segmentectomy.
Prachanronarong K, Kim E
Semin Intervent Radiol. 2021; 38(4):425-431.
PMID: 34629709
PMC: 8497094.
DOI: 10.1055/s-0041-1735529.
Current Approach to Planning Angiography and MAA Administration.
Commander C, Mauro D
Semin Intervent Radiol. 2021; 38(4):397-404.
PMID: 34629705
PMC: 8497078.
DOI: 10.1055/s-0041-1735616.